Canadian COVID-19 vaccine manufacturer Medicago Inc. shutting down
Medicago Inc., the Quebec-based drug manufacturer of a Canadian COVID-19 vaccine and other plant-based drugs, is being shut down by parent company Mitsubishi Chemical Group.

Medicago Inc., the Quebec-based drug manufacturer of a Canadian COVID-19 vaccine and other plant-based drugs, is being shut down by parent company Mitsubishi Chemical Group.
Authorities announced Friday that travel between Hong Kong and China will no longer require COVID-19 PCR tests nor be held to a daily limit, as both places seek to drive economic growth.
People arriving on flights to Canada from China, Hong Kong and Macao will have to do a COVID-19 test before they board for another two months, after Canada announced it would renew border restrictions on air travel from those areas Thursday.